PALO ALTO, Calif., July 29, 2025, 180 Life Sciences Corp. announced a major shift in direction. The company plans to hold Ether (ETH) as its primary reserve asset. After the transaction, it will rebrand as ETHZilla Corporation. The move reflects a deep commitment to the Ethereum network and its growing role in global finance.
The deal includes a $425 million private equity investment. Shares will sell at $2.65 each, with some investors receiving pre-funded warrants. The transaction is set to close by August 1. The company also has approval to offer up to $150 million in debt securities soon after.
ETHZilla raises funds to build an Ethereum treasury
These initiatives will generate funds to purchase ETH, meet corporate expenses, and settle transaction fees. Over 60 investors are involved in the transaction. They are a combination of names from conventional finance as well as from the Ethereum space. Representative participants are from Electric Capital, Polychain, GSR, Frax, Compound, and others.
ETH builders like Sreeram Kannan, Danny Ryan, and Vivek Raman are backing the plan. Many will also guide the company going forward. After the deal closes, the company will keep its current leadership team. Electric Capital will manage the ETH assets. They plan to use staking, lending, and other tools to generate on-chain yield.
It strives to be better than ordinary ETH staking with risks minimized. The company strives to gain value appreciation right away. Its approach couples long-term holding of ETH with active yield strategies. The new treasury model tries to offer public investors entry into Ethereum through a gateway to the stock market.
ETHZilla launches to bring Ethereum to public markets
Strategic partner Etherealize will support this plan. A group of DeFi experts will advise on how to grow the treasury and help the Ethereum ecosystem. Legal and financial support came from multiple firms. Clear Street led the private offering.
Reed Smith, The Loev Law Firm, and Gunderson Dettmer acted as legal advisers. Paul Hastings counselled the placement agent. The sale offer is a private sale, and it remains unregistered to date with the SEC. There will be a resale registration statement.
The firm intends to make the shares publicly tradeable after having satisfied all applicable legal conditions. 180 Life Sciences gears up for a fearless new direction. The new ETHZilla Corporation seeks to wield Ethereum’s might to public market investors.
